EULAR Task Force Ongoing Initiatives

 

  • QoC002 - EULAR Points to Consider for the definition of clinical and imaging features suspicious for progression to psoriatic arthritis, 2021-22D
    McGonagle/J. Smolen

  • QoC003 - EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritides and a recent history of cancer, 2021-22 
    J.-E. Gottenberg

  • QoC004 - Development of EULAR/ACR Criteria for Disease Activity and Response in Giant Cell Arteritis
    Dejaco, Langford

  • QoC006 - Development and Validation of a EULAR disease activity score in Antiphospholipid syndrome
    M. Tektonidou

  • QoC007 - Recommendations for a core data set to support translational and observational research and clinical care in systemic lupus erythematosus
    M. Schneider

  • QoC008 - Update of the 2016 EULAR recommendations for the management of ANCA-associated vasculitis
    B. Hellmich

  • QoC010 - Update of EULAR recommendations for the treatment of Systemic Sclerosis
    Y. Allanore, F. Del Galdo

  • QoC011 - EULAR/PRES Recommendation for the Diagnosis and Management of Systemic Juvenile Idiopathic Arthritis (sJIA) and Adult Onset Still's Disease (AOSD)
    B. Fautrel /F.De Benedetti

  • QoC012 - EULAR Update proposal Antirheumatic drugs in pregnancy and lactation
    F. Förger

  • QoC013 - 2023 Update of the EULAR recommendations for the use of imaging in the diagnosis and management of large vessel vasculitis, (1 year, 2 months)
    C.Dejaco

  • QoC014 - ACR-EULAR Development of Classification Criteria for Immune Related Adverse Events: Inflammatory Arthritis
    A.Meara-M.Kostine

  • QoC015 - Update of the EULAR recommendations for the Management of SLE
    Dimitrios Boumpas

  • QoC016 - Update of the EULAR Recommendations for the management of psoriatic arthritis with pharmacological therapies
    Josef Smolen

  • CLI121 - Classification Criteria for pediatric chronic recurrent multifocal osteomyelitis (CRMO) joint call 2019 (ACR/EULAR joint project)
    Seza Özen Yongdong Zhao

  • CLI119 - Joint EULAR/ERS diagnostic and therapeutic approach of interstitial lung disease in connective tissue diseases
    Anna-Maria Hoffmann-Vold

  • CLI117 - EULAR Classification criteria for haemochromatosis arthropathy
    Patrick Kiely

  • CLI116ACR - EULAR Classification Criteria for Calcium Pyrophosphate Depostion Disease (CPDD)
    Hyon Choi / Abhishek Abhishek

  • CLI113 - Development And Validation of a EULAR disease activity score in adult onset Still’s Disease: the “DAVID” project
    Roberto Giacomelli

  • CLI108 - EULAR-ACR Classification Criteria for Antisynthetase Syndrome (CLASS)
    Aggarwal Rohit (ACR), Cavagna Lorenzo (EULAR)

  • CLI107 - ACR/EULAR Classification Criteria for Antiphospholipid Syndrome
    Doruk Erkan (ACR), Stephan Zuily (EULAR)

  • CLI098 - ACR-EULAR Criteria for Treatment Response for ANCA‐Associated Vasculitis
    Peter Merkel, Gunnar Tomasson

  • CLI088 - The Development of New Classification Criteria for Hand Osteoarthritis
    Margreet Kloppenburg

  • IMG003-EULAR recommendations /criteria for the appropriate use of musculoskeletal ultrasound in rheumatology clinical practice (Imaging)
    Maria-Antonietta d'Agostino

  • IMG017 - EULAR Recommendations for the use of imaging in crystal-induced arthropathies in clinical practice
    Peter Mandl

  • IMG013 - Imaging: EULAR Recommendations for the use of imaging in patient with mechanical back pain
    Gilles Fournier

  • CLI076 / IMG006 - Imaging: Development of a standardized training model for ultrasound-guided synovial biopsy’s in small and large joints
    Esperanza Naredo, Ingrid Möller ex Kelly

  • CLI050 /IMG003 - Imaging: EULAR recommendations /criteria for the appropriate use of musculoskeletal ultrasound in rheumatology clinical practice (Imaging)
    Maria-Antonietta d'Agostino

  • RES001 - EULAR Points to consider on risk stratification of populations for RA prevention studies, 2021-22
    A. van der Helm

  • EPI019 - 3rd RODs meeting Amsterdam
    Elena Nickiphorou, Loreto Carmona

  • EPI010 - Tool Box
    Loreto Carmona (Sofia Ramiro is the new responsible since 2019)

  • EPI009 - Patient reported outcome initiative (PRO call)
    Deborah Symmons, Loreto Carmona

  • SCI019 - EULAR recommendations/point to consider points to consider for the measurement and reporting of interferon activity in clinical research and future clinical application
    Edward Vital

  • SCI016 - EULAR recommendations for the use and interpretation of laboratory diagnostic tests for the management of systemic autoimmune rheumatic diseases
    Johan Rönnelid, Pier Luigi Meroni

  • SCI015 - Characterization of new tentative international reference reagents for clinical laboratory immunology/rheumatology analyses
    Johan Rönnelid

  • HPR057 - Research Grant: Quality indicators for Hand Osteoarthritis
    Daniel Huseby Bordvik

  • HPR056 - How to best support research activities among health professionals in
    rheumatology (HPRs)

    E.Mosor/K.Hoeper

  • HPR055 - Update of the EULAR recommendations for non-pharmacological core management of hip and knee osteoarthritis
    N. Østerås

  • HPR054 - Translation of two upcoming recommendations with high relevance for HPRs into 6 languages and disseminate them in at least 8 countries:
    Translation & development of national quality improvement plans

    HPR: A.-K. Rausch

  • HPR053 - Online Course: Evidence Based Practice for HPR in rheumatology -
    from the database to EULAR recommendations. A journey through the body of evidence

    HPR: M. Testa, V. Ritschel

  • HPR052 - EULAR points to consider/recommendations for the management of fatigue in people with inflammatory rheumatic diseases
    E. Durres

  • HPR051 - EULAR Implementation of a mobile health app for the self-management of juvenile-onset rheumatic and musculoskeletal diseases during transitional care: a patient-centered approach. The Move-Up implementation project
    Fernando Estévez-López

  • HPR048 - Defining and optimising the use of qualitative research in the development of EULAR recommendations/points to consider
    Annette de Thurah

  • HPR047 - Increasing work participation across Europe, part II
    Ross Wilkie

  • HPR046 - EULAR recommendations/points to consider for the non-pharmacological management of connective tissue diseases with focus on systemic lupus erythematosus and systemic sclerosis
    Carina Boström

  • HPR044 - Increasing work participation across Europe
    Ross Wilkie

  • HPR043 - Implementation of Physical Activity into routine Clinical pracTice in Rheumatic Musculoskeletal Disease: The IMPACT-RMD study
    Georg Metsios

  • HPR041 - People with RMDs will act as multipliers to support others to stay in or return to paid and unpaid work
    Erika Mosor

  • EDU049 - School Fellows Classroom: EULAR standards for the training of European rheumatologists
    C.Edwards

Related Information

Call for Task Force members

We look for experienced investigators in the mentioned fields of rheumatology. To apply as task force member, please send your one-page letter of interest to participate and a short CV to Simona Lupatin (simona.lupatin@eular.org).

EULAR SOP for EULAR Recommendations/Points to Consider selection of task force members (PDF)


Application for Project Grants

EULAR welcomes project applications from rheumatologists across Europe designed for developing EULAR Recommendations, EULAR Criteria, EULAR Points to Consider, or similar projects.

See more


EULAR Recommendations

The EULAR Committees regularly establish and publish recommendations for the treatment of various rheumatic disorders. Each of these recommendations are developed by a Task Force of specialists in their field.

See more